Articles by Beth Herskovits - Pharmaceutical Executive

ADVERTISEMENT

Articles by Beth Herskovits

You Can't Please Everyone

Jan 17, 2007

Consumers still aren't happy, but industry calls FDA's addition to PDUFA 'an important new step.'

Lilly Closes Zyprexa Case

Jan 10, 2007

(And the Times' front-page pounding had nothing to do with it.)

We 'Heart' Biomarkers, Say AstraZeneca and Merck

Jan 10, 2007

Cardio competitors team up to find new ways of preventing heart attacks.

Revenge of the Nerds

Jan 10, 2007

Biotech companies, for years at the mercy of their deep-pocketed pharma partners, are finally holding the strings.

Lost in the Sauce

Jan 3, 2007

Government report paints picture of ineffectual FDA buried by avalanche of ads.

Returning the Favor

Jan 3, 2007

Multi-company campaign hopes to cast clinical trial participants as 'heroes.'

CASE STUDY: Januvia's Hasty Arrival

Jan 3, 2007

Merck plays 'to win' in one of its first launches since implementing a new cost-cutting model.

Opening the Floodgates

Dec 20, 2006

FDA's revisions to guidelines on expanding access to experimental drugs intensify an already murky issue for pharma.

Staying the Course

Dec 20, 2006

At its annual pipeline debut, the company introduced its own CETP-inhibitor--with doubts.

ADVERTISEMENT

Click here